Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloramphenicol ointment vs recombinant human epidermal growth factor for facial burn wound healing
TCTR20171004003Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Nov 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in burn injury comparing Chloramphenicol ointment with Recombinant human epidermal growth factor (2 arms). Planned start Nov 2017; status: not yet recruiting.
02
Drugs
chloramphenicolnepidermin
03
Conditions
burn injury
Beyond the preview
Go deeper on TCTR20171004003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171004003.